Laurion Capital Management LP Ikena Oncology, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$1.33 - $4.4 $192,783 - $637,780
-144,950 Reduced 28.01%
372,613 $734,000
Q2 2023

Aug 14, 2023
SELL
$3.5 - $7.31 $40,029 - $83,604
-11,437 Reduced 2.16%
517,563 $3.4 Million
Q2 2022

Aug 15, 2022
BUY
$3.23 - $7.4 $1.71 Million - $3.91 Million
529,000 New
529,000 $2.34 Million

Others Institutions Holding IKNA

# of Institutions
61
Shares Held
30.6M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $55.5M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email